Comparative short-term effects of oscillatory mobilization and mulligan MWM on pain, disability, and range of motion among De Quervain's tenosynovitis patients- a randomized clinical trial.

BACKGROUND

De Quervain's tenosynovitis is characterized by thickening and swelling of the extensor retinaculum. The most reported symptoms are pain, swelling, and discomfort over the radial styloid.

OBJECTIVE

To determine the short-term effects of oscillatory Mobilization and Mobilization with movement on pain, Range of Motion and Disability among De-Quervain's tenosynovitis.

METHODS

This single-blinded randomized clinical trial with parallel assignment was conducted at Arif Memorial Teaching Hospital on 28 patients from August 2023 to October 2023. The subjects were allocated to groups A and B, with 14 patients in each group. Group A received mobilization with movement, and Group B received oscillatory mobilization for two weeks with three sessions per week. Data were taken of each patient before and after treatment through a numeric pain rating scale for pain, a goniometer for a range of motion, and patient-related wrist evaluation for Disability. The data were analyzed using SPSS V. 22, and appropriate statistical tests were used based on data distribution and taking p < 0.05 as significant.

RESULTS

The study comprised 28(100%) participants, with 14 (50%) in each group. There were 08 males (57.1%) and 6 (42.9%) female participants in group A, whereas there were seven male (50.0%) and 7 (50.0%) female participants in group B. The mean age of patients in group A was 32.857 ± 5.815, and in group B was 31.642 ± 5.838. The pain pretreatment in Group A was 8.28 ± 1.49, while in Group B was 8.50 ± 1.22, whereas the post-treatment in Group A was 3.50 ± 0.94 while in Group B was 4.28 ± 1.14. The paired t-test showed a significant difference between the pre-and post-treatment pain scores, disability index, and range of motion with a p-value < 0.05. The Patient Rated Wrist Evaluation score value at pretreatment in Group A was 78.71 ± 4.16; in Group B, it was 76.86 ± 3.09, whereas the post-treatment in Group A was 33.39 ± 5.48, while in Group B was 38.96 ± 3.66. The independent t-test showed a significant difference between both groups for pain disability index and range of motion with a p-value < 0.05.

CONCLUSION

The study concluded that both treatments have short-term effects, but Mobilization with movement was more effective than Oscillatory movements for pain, ROM, and Disability in patients with De Quervain's tenosynovitis.

CLINICAL TRIAL REGISTRY: IRCT20220604055072N2.